Publications by authors named "Martin Wolfsegger"

Claim this Profile
P
Pharmacokinetic-Pharmacodynamic Comparison of Recombinant and Plasma-Derived von Willebrand Factor in Patients with von Willebrand Disease Type 3.
Alexander Bauer, Sofia Friberg-Hietala, Giovanni Smania, Martin Wolfsegger

J Blood Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of pharmacokinetic linearity after repeated drug administration.
Alexander Bauer, Matts Kagedal, Martin J Wolfsegger

Pharm Stat· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critical Remarks on Reference-Scaled Average Bioequivalence.
Helmut Schütz, Detlew Labes, Martin J Wolfsegger

J Pharm Pharm Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing goodness-of-fit for evaluation of dose-proportionality.
Martin J Wolfsegger, Alexander Bauer, Detlew Labes, Helmut Schütz, Richardus Vonk

Pharm Stat· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential of the estimands framework for clinical pharmacology trials: Some discussion points.
Arne Ring, Martin J Wolfsegger

Br J Clin Pharmacol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling to Predict Factor VIII Levels Associated with Zero Bleeds in Patients with Severe Hemophilia A Initiated on Tertiary Prophylaxis.
Pratima Chowdary, Kathelijn Fischer, Peter W Collins, Amy Cotterill, Barbara A Konkle, Martin Wolfsegger

Thromb Haemost· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SHP656, a polysialylated recombinant factor VIII (PSA-rFVIII): First-in-human study evaluating safety, tolerability and pharmacokinetics in patients with severe haemophilia A.
Andreas Tiede, Geoffrey Allen, Alexander Bauer, Pratima Chowdary, Peter Collins, Martin Wolfsegger

Haemophilia· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Factor VIII Polysialylation: Identification of a Longer-Acting Experimental Therapy in Mice and Monkeys.
Helmut Glantschnig, Alexander Bauer, Karima Benamara, Michael Dockal, Veronika Ehrlich, Martin Wolfsegger

J Pharmacol Exp Ther· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetic modeling and simulation of immunoglobulin exposure with varying dosing intervals of subcutaneous immunoglobulin 20% (Ig20Gly) in patients with primary immunodeficiency diseases.
Todd Dumas, N Seth Berry, Martin Wolfsegger, Stephen Jolles, Barbara McCoy

Int Immunopharmacol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, disease-modifying activity, and safety of an experimental therapeutic targeting an immunological isoform of macrophage migration inhibitory factor, in rat glomerulonephritis.
Werner Höllriegl, Alexander Bauer, Bernhard Baumgartner, Barbara Dietrich, Patrice Douillard, Martin Wolfsegger

Eur J Pharmacol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjustment of endogenous concentrations in pharmacokinetic modeling.
Alexander Bauer, Martin J Wolfsegger

Eur J Clin Pharmacol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombin based gelatin matrix and fibrin sealant mediated clot formation in the presence of clopidogrel.
Joseph F Dwyer, Jill A McCoy, Ziping Yang, Michael Husser, Heinz Redl, Martin Wolfsegger

Thromb J· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, controlled comparison of advanced hemostatic pads in hepatic surgical models.
Kevin M Lewis, Jeff McKee, Alexandra Schiviz, Alexander Bauer, Martin Wolfsegger

ISRN Surg· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A hybrid method to estimate the minimum effective dose for monotone and non-monotone dose-response relationships.
Martin J Wolfsegger, Georg Gutjahr, Werner Engl, Thomas Jaki

Biometrics· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of methods for classifying samples as truly specific with confirmatory immunoassays.
Thomas Jaki, John-Philip Lawo, Martin J Wolfsegger, Peter Allacher, Frank Horling

J Pharm Biomed Anal· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimation in AB/BA crossover trials with application to bioequivalence studies with incomplete and complete data designs.
Thomas Jaki, Philip Pallmann, Martin J Wolfsegger

Stat Med· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Authors' reply to Comments on 'Estimation in AB/BA crossover trials with application to bioequivalence studies with incomplete and complete data designs".
Thomas Jaki, Philip Pallmann, Martin J Wolfsegger

Stat Med· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients.
Shawn F J Whelan, Christoph J Hofbauer, Frank M Horling, Peter Allacher, Martin J Wolfsegger

Blood· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-compartmental estimation of pharmacokinetic parameters for flexible sampling designs.
Thomas Jaki, Martin J Wolfsegger

Stat Med· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A formal comparison of different methods for establishing cut points to distinguish positive and negative samples in immunoassays.
Thomas Jaki, John-Philip Lawo, Martin J Wolfsegger, Julia Singer, Peter Allacher

J Pharm Biomed Anal· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-component polyethylene glycol surgical sealant influence on intraperitoneal infection in a refined rodent model.
Kathleen E Rodgers, Florence G Burleson, Gary R Burleson, Martin J Wolfsegger, Kevin M Lewis

Am J Obstet Gynecol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing bioequivalence in complete and incomplete data designs using AUCs.
Thomas Jaki, Martin J Wolfsegger, John-Philip Lawo

J Biopharm Stat· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing systemic drug exposure in repeated dose toxicity studies in the case of complete and incomplete sampling.
Martin J Wolfsegger, Thomas Jaki

Biom J· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A note on statistical analysis of organ weights in non-clinical toxicological studies.
Martin J Wolfsegger, Thomas Jaki, Barbara Dietrich, Jackie A Kunzler, Kerry Barker

Toxicol Appl Pharmacol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-compartmental estimation of pharmacokinetic parameters in serial sampling designs.
Martin J Wolfsegger, Thomas Jaki

J Pharmacokinet Pharmacodyn· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis